• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.23% Nasdaq Down 0.63%

    Inovio Pharmaceuticals, Inc. (INO)

    -NasdaqGS
    10.06 Down 0.30(2.85%) 4:00PM EDT
    |After Hours : 10.05 Down 0.00 (0.01%) 4:17PM EDT
    Add to Portfolio
    Prev Close:10.35
    Open:10.40
    Bid:10.05 x 6500
    Ask:10.06 x 9300
    1y Target Est:20.80
    Beta:3.56
    Earnings Date:May 11 - May 15 (Est.)
    Day's Range:9.75 - 10.57
    52wk Range:6.33 - 14.20
    Volume:1,628,888
    Avg Vol (3m):975,490
    Market Cap:610.75M
    P/E (ttm):N/A
    EPS (ttm):-0.65
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for INO

    Comparison

    Symbol% ChgMkt Cap
    INODown 2.85%610.75M
    AZNDown 1.43%89.38B
    PFEDown 1.93%212.39B
    SNYUp 1.02%136.71B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):60.12
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.73
    Quarterly EPS Est (Mar-15) :-0.11
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Inovio Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops active DNA immunotherapies and vaccines in combination with proprietary electroporation delivery devices to prevent and treat cancers and infectious diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback